 SOLANA BEACH, Calif. and SALT LAKE CITY, July 21, 2021 GLOBE NEWSWIRE -- ClearPoint Neuro, Inc. Nasdaq: CLPT the Company, a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a joint agreement with Blackrock Neurotech to develop an automated surgical solution for implanting Brain Computer Interfaces BCIs into patients with a wide range of neurological disorders including paralysis, ALS, blindness, hearing loss and more. This partnership will seek to leverage ClearPoints platform and software to deliver, for the first time, a clinical solution for surgeons that is more streamlined and effective than other BCI implantation surgeries performed to date. 